English

Español

العربية

Bahasa Indonesia

Bahasa Melayu

Tiếng Việt

ภาษาไทย

Русский язык

Français

Italiano

Turkish

Português

日本語

한국어

简中

繁中

[CSL Assesses Potential Tariff Exemptions For U.s.-made Drugs In China] Australia's CSL Ltd Is Evaluating Whether Its U.s.-manufactured Drugs, Such As Human Albumin Used In Surgery, Will Be Exempted From The 125% Tariffs China Imposed On U.S. Goods. Reports Indicate China Is Granting Tariff Exemptions On Select U.S. Imports, Potentially Including Pharmaceuticals, And CSL Is Seeking To Determine If Its Critical Medicines Qualify. CSL Is Also Working To Diversify Its Global Supply Chain For China.

Quick access to 24/7

Quick access to more editor-selected real-time news

Exclusive video for free

FastBull VIPject team is dedicated to create exclusive videos

Follow More Symbols

You can add more symbols to your watchlist.

More comprehensive macro data and economic indicators

More comprehensive historical data on indicators to help analyze macro markets

Member-only Database

Comprehensive forex, commodity, and equity market data